Frank PanaroDirector, Finance Valuation and Business Case at BayerSpeaker
Profile
Frank has been in Pharma/Biotech for over 20 years, with 8 years in the lab as a Molecular Biologist and over 15 years in Finance, supporting all areas of the business from R&D through Commercial. He holds a Bachelor of Science in Biology from Siena University, a Master of Science Degree in Molecular Biology from NYU and an MBA in Finance from Pace University. Frank's prior roles before joining Bayer include Director of Corporate Finance at Sunovion, Director of Commercial Finance at bluebird bio, Director of Gross to Net Finance at Purdue, and Associate Director of Forecasting US Oncology at Boehringer Ingelheim.
Agenda Sessions
Financial Reporting Considerations When Transitioning From Clinical to Commercial
, 4:30pmView Session
